Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.

[1]  M. Pavesi,et al.  Prognostic importance of the cause of renal failure in patients with cirrhosis. , 2011, Gastroenterology.

[2]  M. Pavesi,et al.  Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension , 2010, Hepatology.

[3]  M. Merli,et al.  Cirrhotic patients are at risk for health care-associated bacterial infections. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  P. Mehler,et al.  Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[6]  S. Miyakis,et al.  Risk stratification and outcome of cellulitis admitted to hospital. , 2010, The Journal of infection.

[7]  R. Schrier,et al.  Renal failure in cirrhosis. , 2009, The New England journal of medicine.

[8]  J. Vincent,et al.  Severe sepsis in cirrhosis , 2009, Hepatology.

[9]  June-Sung Lee,et al.  Renal Dysfunction Induced by Bacterial Infection other than Spontaneous Bacterial Peritonitis in Patients with Cirrhosis: Incidence and Risk Factor , 2009, Gut and liver.

[10]  F. Salerno,et al.  The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. , 2009, Journal of hepatology.

[11]  B. Gómez-Anson,et al.  Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis , 2009, The American Journal of Gastroenterology.

[12]  K. Koh,et al.  Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  R. Terg,et al.  Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[14]  S. Corrao,et al.  Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. , 2009, Annals of internal medicine.

[15]  W. Byrne,et al.  Hepatic encephalopathy. , 2009, Emergency medicine clinics of North America.

[16]  T. Therneau,et al.  Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.

[17]  P. Tandon,et al.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis. , 2008, Seminars in liver disease.

[18]  Vicente Arroyo,et al.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.

[19]  D. Thabut,et al.  Model for end‐stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure , 2007, Hepatology.

[20]  R. Jalan,et al.  Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? , 2007, Hepatology.

[21]  V. Arroyo,et al.  Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. , 2007, Journal of hepatology.

[22]  P. Angeli,et al.  Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features , 2007, Hepatology.

[23]  M. Navasa,et al.  Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. , 2005, Gastroenterology.

[24]  W. Jiménez,et al.  A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis , 2005, Hepatology.

[25]  J. Hoefs,et al.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club , 2005, Gut.

[26]  P. Ginès,et al.  Management of complications of cirrhosis in patients awaiting liver transplantation. , 2005, Journal of hepatology.

[27]  J. Ariza,et al.  Gram-negative bacillary cellulitis in patients with hepatic cirrhosis , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[28]  R. Fisher,et al.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death , 2004, Hepatology.

[29]  A. Sperber,et al.  Gram-negative cellulitis complicating cirrhosis. , 2004, Mayo Clinic proceedings.

[30]  W. Jiménez,et al.  Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis , 2003, Hepatology.

[31]  F. Gudiol,et al.  Factors Associated with Complications and Mortality in Adult Patients Hospitalized for Infectious Cellulitis , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[32]  L. Martín-Herrera,et al.  Dilutional hyponatremia in patients with cirrhosis and ascites. , 2002, Archives of internal medicine.

[33]  M. Navasa,et al.  Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis , 2002, Hepatology.

[34]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[35]  M. Navasa,et al.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.

[36]  W. Jiménez,et al.  Tumor necrosis factor and interleukin‐6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality , 1998, Hepatology.

[37]  R. Schrier,et al.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. , 1998, The Journal of clinical investigation.

[38]  J. Llovet,et al.  Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis , 1994, Hepatology.